SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 211.06 |
| Enterprise Value ($M) | 175.25 |
| Book Value ($M) | 40.63 |
| Book Value / Share | 0.14 |
| Price / Book | 5.19 |
| NCAV ($M) | 19.37 |
| NCAV / Share | 0.07 |
| Price / NCAV | 10.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.08 |
| Return on Assets (ROA) | -0.79 |
| Return on Equity (ROE) | -1.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.58 |
| Current Ratio | 2.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 40.67 |
| Assets | 61.94 |
| Liabilities | 21.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.88 | 0.00 | |
| 13G | BlackRock, Inc. | 6.50 | 0.00 | |
| 13G | State Street Corp | 5.50 | 1,793.28 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 790,972 | 1,875,405 | 42.18 | |
| 1,147,857 | 2,762,210 | 41.56 | |
| 1,007,451 | 2,173,702 | 46.35 | |
| 812,055 | 2,072,901 | 39.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NRXP – NRx Pharmaceuticals, Inc. | NVCT – Nuvectis Pharma, Inc. |
| OCEA – Ocean Biomedical, Inc. | OCX – OncoCyte Corporation |
| OKYO – OKYO Pharma Limited |
Financial data and stock pages provided by
Fintel.io